Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost and Eptifibatide in Septic Shock
NCT02204852Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Aug 2016
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost, eptifibatide in septic shock. Started Sep 2014; status: completed.
02
Drugs
iloprosteptifibatide
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02204852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02204852.